ArticleThe Journal of neuropsychiatry and clinical neurosciences2021

Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.

Jeffrey CummingsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.